Skip to main content

Telmisartan and Hydrochlorothiazide

NDC 62332-211 · Alembic Pharmaceuticals Inc.

Generic nameTelmisartan and Hydrochlorothiazide
Dosage formTABLET
RouteORAL
Active ingredient(s)TELMISARTAN, HYDROCHLOROTHIAZIDE
Strength25; 80 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

62332-211-10 — 100 TABLET in 1 CARTON (62332-211-10)

62332-211-30 — 30 TABLET in 1 BOTTLE (62332-211-30)

62332-211-91 — 1000 TABLET in 1 BOTTLE (62332-211-91)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62332-088 — Telmisartan, 62332-089 — Telmisartan, 62332-115 — Metoprolol Tartrate and Hydrochlorothiazide, 62332-116 — Metoprolol Tartrate and Hydrochlorothiazide, 62332-117 — Metoprolol Tartrate and Hydrochlorothiazide, 62332-149 — Olmesartan Medoxomil and Hydrochlorothiazide, 62332-150 — Olmesartan Medoxomil and Hydrochlorothiazide, 62332-151 — Olmesartan Medoxomil and Hydrochlorothiazide, 62332-209 — Telmisartan and Hydrochlorothiazide, 62332-210 — Telmisartan and Hydrochlorothiazide, 62559-414 — Benazepril Hydrochloride and Hydrochlorothiazide, 62559-415 — Benazepril Hydrochloride and Hydrochlorothiazide, 62559-416 — Benazepril Hydrochloride and Hydrochlorothiazide, 62559-417 — Benazepril Hydrochloride and Hydrochlorothiazide, 62559-650 — Candesartan Cilexetil and Hydrochlorothiazide, 62559-651 — Candesartan Cilexetil and Hydrochlorothiazide, 62559-652 — Candesartan Cilexetil and Hydrochlorothiazide, 62559-660 — Candesartan Cilexetil and Hydrochlorothiazide, 62559-661 — Candesartan Cilexetil and Hydrochlorothiazide, 62559-662 — Candesartan Cilexetil and Hydrochlorothiazide, +947 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels